Pneumotox Online
v2.2
  • RSS Feed
  • Contact
  • News
  • Diagnosing DIRD
  • Browse
  • Available on AppStore Available on AppStore

The Drug-Induced Respiratory Disease Website

Philippe Camus, M.D.

Dijon, France

  • Home
  • Browse by »
  • Drugs
  • Patterns

Gemcitabine

5

I.a Pneumonitis (ILD), acute and/or severe (may cause ARDS)

2
Last update : 11/05/2012
 
Search
Advanced search
Identify causative drugs
Diagnosing DIRD
1
Drug and radiation history
2
Drug singularity - Correct identification of the drug
3
Consistent timing of exposure v. onset of symptoms
4
Clinical, imaging, BAL, pathological pattern consistent with the specific drug
5
Careful exlusion of another cause
6
Remission of symptoms with removal of drug
7
Recurrence with rechallenge (rarely advisable)
8
Causality assessment
More detailed checklist

Publications

Clinical features and correlates of gemcitabine-associated lung injury: findings from the RADAR project.
Cancer 2006 May 01;106;2051-7 2006 May 01
Hypersensitivity pneumonitis in advanced non-small-cell lung cancer patients receiving gemcitabine and paclitaxel: report of two cases and a review of the literature.
Clinical lung cancer 2002 Jul;4;52-6 2002 Jul
[Interstitial lung disease in a patient given gemcitabine].
Revue de pneumologie clinique 2002 Feb;58;23-6 2002 Feb
Side effects of chemotherapy. Case 3. Acute interstitial pneumonitis related to gemcitabine.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000 Feb;18;697-8 2000 Feb

Powered by

  • ^
  • Contact
  • Cookies
  • About

The Pneumotox website uses cookies. By accessing or using our website, you consent to the collection, use and disclosure of the garnered information in accordance with our privacy policy.

Learn more about cookies